InconclusiveClinical Trial2025
Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom (P8-9.005)
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/A